Anus Laboratories Ltd
Anus Laboratories Ltd (532981): company summary
Anus Laboratories Ltd (532981) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Anus Laboratories Ltd (532981) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 18.2% a year over three years; profit fell 42.8% a year, behind revenue — margins are under pressure. Return on equity is 2.3%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Held back by quality (2.9). The latest financials on file are more than 18 months old, so treat the fundamental measures with caution. Scored on 3 of 5 measures.
DocStoX score
Low confidenceScored on 3 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Profitable in all of the last 5 years
- Revenue compounding 20% a year
- Profit shrinking 27% a year
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Anus Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Anus Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Anus Laboratories Ltd with peers
Related tools & concepts
Value Anus Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.

